---
title: "autosomal dominant polycystic kidney disease"
alias: ADPKD
slug: "autosomal-dominant-polycystic-kidney-disease"
date: "2023-07-25"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[kidney disease]]

# autosomal dominant polycystic kidney disease

- å¤šå›Šè…Žè‡ªé«”é¡¯æ€§å¤šå›Šè…Ž(Autosomal Dominant Polycystic Kidney disease, å…¨å ADPKDï¼Œç°¡ç¨±å¤šå›Šè…Ž)
- æ˜¯: ä¸€ç¨®é«”æŸ“è‰²é«”é¡¯æ€§åŸºå› è®Šç•°çš„ â†’ éºå‚³ç—…ï¼Œç››è¡ŒçŽ‡ç´„ ç‚º: 1ï¼š400.1000ï¼Œ
- ç‚º: ç¬¬ 4 å¤§é€ æˆ â†ª æœ«æœŸè…Žç—…çš„ â†’ åŽŸå› ï¼Œ
- ä¹Ÿ æ˜¯: éºå‚³ç–¾ç—…ä¸­é€ æˆ â†ª æœ«æœŸè…Žç—…çš„ â†’ ç¬¬ä¸€å¤§åŽŸå› ã€‚
- å¤šå›Šæ€§è…Žç—…è®Šæ‚£è€…çš„ â†’ è‚è‡Ÿã€èƒ°è…ºï¼Œè„¾è‡Ÿï¼Œåµå·¢å’Œå¤§è…¸éƒ½æœ‰ ðŸ˜‰ å¯èƒ½å‡ºç¾å›Šè…«

## Initial management

1. è¡€å£“ â†’ é¦–é¸é™å£“è—¥ç‰© ç‚º: ACEI/ARBï¼Œç›®æ¨™å¦‚ä¸‹ï¼š
   - For 18-50 y/o & eGFR >60=> BP<110/75mmHg
   - For others => BP<130/80 mmHg, similar to patients with other causes of CKD.
2. é™éˆ‰ï¼šç›®æ¨™ ç‚º: ä¸€å¤© âœ– ä¸è¶…éŽ 2 å…‹
3. å¢žåŠ  â†‘ æ°´åˆ†æ”å–ï¼šç›®æ¨™ ç‚º: ä¸€å¤©å–è¶…éŽ 3L çš„ â†’ fuid (é™¤éž eGFR å°æ–¼ 30ï¼Œæˆ–æœ‰ä½Žéˆ‰çš„ â†’ é¢¨éšª(eg, taking a thiazide diuretic)

## Additional management for high risk patients

1. Tolvaptan (a short-acting competitive inhibitor of V2R, completely blocks vasopressin action on cyst production)ï¼š
   - ç”¨åœ¨ â†£ eGFR â‰¥25 çš„ â†’ ç—…äºº
   - æ˜¯: æ²»ç™‚ä¸­å°é é˜²è…Žçµ²çƒéŽæ¿¾çŽ‡ä¸‹é™ â†“ æœ€æœ‰ benefit çš„ â†’ æ²»ç™‚
